Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.

Leyden D, Ahmed N, Hassan HT.

Anticancer Res. 2000 Jan-Feb;20(1A):133-8.

PMID:
10769645
2.

Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.

Kuo ML, Hwang HS, Sosnay PR, Kunugi KA, Kinsella TJ.

Cancer J. 2003 Jul-Aug;9(4):277-85.

PMID:
12967138
3.

The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.

Kuo ML, Kunugi KA, Lindstrom MJ, Kinsella TJ.

Cancer J Sci Am. 1997 May-Jun;3(3):163-73.

PMID:
9161782
4.

Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.

Szekeres T, Fritzer M, Strobl H, Gharehbaghi K, Findenig G, Elford HL, Lhotka C, Schoen HJ, Jayaram HN.

Blood. 1994 Dec 15;84(12):4316-21.

5.

[The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].

Findenig G, Vielnascher E, Göbl R, Fritzer-Szekeres M, Szekeres T.

Wien Klin Wochenschr. 1995;107(22):694-7. Review. German.

PMID:
8533431
7.

Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.

Woynarowska BA, Roberts K, Woynarowski JM, MacDonald JR, Herman TS.

Radiat Res. 2000 Oct;154(4):429-38.

PMID:
11023607
9.

Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.

Fritzer-Szekeres M, Novotny L, Romanova D, Göbl R, Sedlak J, Vachalkova A, Rauko P, Elford HL, Szekeres T.

Life Sci. 1998;63(7):545-52.

PMID:
9718080
10.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
11.
12.

Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.

Szekeres T, Gharehbaghi K, Fritzer M, Woody M, Srivastava A, van't Riet B, Jayaram HN, Elford HL.

Cancer Chemother Pharmacol. 1994;34(1):63-6.

PMID:
8174204
13.

Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.

Fritzer-Szekeres M, Salamon A, Grusch M, Horvath Z, Höchtl T, Steinbrugger R, Jäger W, Krupitza G, Elford HL, Szekeres T.

Biochem Pharmacol. 2002 Aug 1;64(3):481-5.

PMID:
12147300
14.

Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.

Fritzer-Szekeres M, Grusch M, Luxbacher C, Horvath S, Krupitza G, Elford HL, Szekeres T.

Exp Hematol. 2000 Aug;28(8):924-30.

PMID:
10989193
15.

Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma.

Macchia G, Valentini V, Mattiucci GC, Mantini G, Alfieri S, Digesù C, Deodato F, Trodella L, Doglietto GB, Cellini N, Morganti AG.

Tumori. 2007 Jan-Feb;93(1):53-60.

17.

Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.

Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.

Oncogene. 2002 Nov 7;21(51):7883-90.

18.

Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.

Szekeres T, Vielnascher E, Novotny L, Vachalkova A, Fritzer M, Findenig G, Göbl R, Elford HL, Goldenberg H.

Eur J Clin Chem Clin Biochem. 1995 Nov;33(11):785-9.

PMID:
8620054
19.

Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.

Iyamu EW, Adunyah SE, Elford HL, Fasold H, Turner EA.

Biochem Biophys Res Commun. 1998 Jun 29;247(3):759-64.

PMID:
9647767
20.

Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas.

Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH; Pancreatic Tumor Study Group.

Am J Clin Oncol. 2005 Jun;28(3):227-33.

PMID:
15923793

Supplemental Content

Support Center